Levels of Aβ are poorly associated with the severity of dementia in Alzheimer’s disease individuals, while tau neurofibrillary tangles levels are more closely associated with cognitive symptoms.10 Given this information, the ability to measure tau burden in living persons is crucial in establishing an accurate diagnosis of Alzheimer’s disease and predicting one’s risk towards clinical progression.25 The gene discussed is MAPT; the disease is dementia.